课题基金 / 基金详情

项目摘要

项目成果

SHELLI R KESLER的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):随着越来越多的儿童在侵袭性脑肿瘤中存活下来,例如髓母细胞瘤(MB),这是第二种最常见的肿瘤类型,这些肿瘤的认知后遗症及其治疗开始受到越来越多的关注。这种关注尤其集中在这些认知障碍对患者及其家人造成的广泛、长期的残疾上。研究表明,抗癌治疗(化疗和头颅放射治疗)会增加儿童长期认知缺陷的风险,而且这些损害往往是进行性的。因此,从寿命的角度来看,干预以改变这一轨迹的前景具有巨大的意义--可能影响学校服务、家庭动态、职业准备和社会服务支持。然而,影响患有甲基溴或其他类型癌症的儿童认知障碍风险的因素尚未得到充分研究。该项目的总体目标是使用先进的多模式磁共振成像(MRI)技术、重点基因分析和认知行为评估来阐明MB及其治疗对功能神经解剖学和认知行为结果的影响。其具体目的是:1)研究MB儿童认知功能障碍和下降的神经解剖学和神经功能基础;2)阐明MB儿童认知结果性别差异的神经生物学因素;3)确定遗传、人口统计学和医学变量在预测MB儿童认知轨迹方面的交互作用。40名患有MB的儿童和30名年龄和性别匹配的3-14岁健康对照组儿童在基线和12个月时接受全面的神经心理和神经成像评估。此外,还将从所有受试者的唾液样本中提取DNA,并对儿茶酚-O-甲基转移酶(COMT)进行基因分型,据信这种酶会影响脑损伤患者的认知结果。这项研究的最终目标是激励制定更具体和更精确的干预措施,以及更好地了解何时最需要干预和最有效的干预措施。这里提出的研究也将有助于更广泛地了解。相关性:这项研究的最终目标是激励为癌症儿童制定更具体和更精确的干预措施,以及更好地了解何时最需要和最有效的干预措施。这里提出的研究还将有助于更广泛地了解早期癌症相关脑损伤如何影响人类的大脑发育和神经组织。
英文摘要
DESCRIPTION (provided by applicant): With the rising number of children who survive invasive brain tumors such as medulloblastoma (MB) which is the second most common tumor type, cognitive sequelae of these neoplasms and their treatments have begun to receive increased attention. This attention is particularly focused on the extensive, long-term disabilities that these cognitive impairments pose for patients and their families. Studies indicate that anti- cancer treatments (chemotherapy and cranial radiation) increase the risk for long-term cognitive deficits in children and that these impairments are often progressive. The prospect of intervening to change this trajectory thus has tremendous significance from a lifespan perspective - potentially affecting school services, family dynamics, vocational readiness and social services support. However, factors mediating the risk for cognitive impairments in children with MB or other types of cancer have not been adequately explored. The overarching aim of this project is to use advanced, multi-modal magnetic resonance imaging (MRI) techniques, focused genetic analyses and cognitive-behavioral assessment to elucidate the effects of MB and its treatments on functional neuroanatomy and cognitive-behavioral outcome. The specific aims are 1) to examine the neuroanatomical and neurofunctional substrates of cognitive impairment and decline in children with MB, 2) elucidate neurobiologic factors subserving gender differences in cognitive outcome among children with MB, and 3) determine the interaction of genetic, demographic and medical variables in predicting the cognitive trajectory of children with MB. Forty children with MB and 30 age and gender matched healthy controls age 3-14 years will undergo comprehensive neuropsychological and neuroimaging assessments at baseline and 12 months. Additionally, DNA will be extracted from saliva samples from all subjects and genotyped for catechol-O-methyltransferase (COMT) which is believed to influence cognitive outcome in individuals with brain injury. The ultimate goal of this research is to inspire the development of more specific and precise interventions, as well as to better understand when intervention is most needed and most effective. The research proposed here also will contribute more broadly to a better understanding. RELEVANCE : The ultimate goal of this research is to inspire the development of more specific and precise interventions for children with cancer, as well as to better understand when intervention is most needed and most effective. The research proposed here also will contribute more broadly to a better understanding of how early cancer- related brain injury affects brain development and neural organization in humans.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/pbc.25022
发表时间: 2014-07
期刊: PEDIATRIC BLOOD & CANCER
影响因子: 3.2
作者: [Kesler, Shelli R., Gugel, Meike, Pritchard-Berman, Mika, Lee, Clement, Kutner, Emily, Hosseini, S. M. Hadi, Dahl, Gary, Lacayo, Norman]
通讯作者: Lacayo, Norman
Using Connectomics and Machine Learning to Predict Survival in Diffuse Glioma
  • 批准号:
    10289350
  • 项目类别:
  • 资助金额:
    $9.31万
  • 财政年份:
    2021
  • 负责人:
    SHELLI R KESLER
  • 依托单位:
Predicting Long-Term Chemotherapy-Related Cognitive Impairment
  • 批准号:
    10617793
  • 项目类别:
  • 资助金额:
    $50.05万
  • 财政年份:
    2019
  • 负责人:
    SHELLI R KESLER
  • 依托单位:
Predicting Long-Term Chemotherapy-Related Cognitive Impairment
  • 批准号:
    9899955
  • 项目类别:
  • 资助金额:
    $61.26万
  • 财政年份:
    2019
  • 负责人:
    SHELLI R KESLER
  • 依托单位:
Predicting Long-Term Chemotherapy-Related Cognitive Impairment
  • 批准号:
    10402797
  • 项目类别:
  • 资助金额:
    $53.53万
  • 财政年份:
    2019
  • 负责人:
    SHELLI R KESLER
  • 依托单位:
海外基金